# Dianthus Therapeutics, Inc.: Form DEF 14A, filed Apr 24, 2020

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: DEF 14A
- Filed: 2020-04-24
- Accepted by EDGAR: Apr 24, 2020, 08:00 ET
- Period: 2020-06-05
- Accession: 0001193125-20-118192
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312520118192/d850972ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312520118192/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312520118192/d850972ddef14a.htm

Filed Apr 24, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-118192. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
